小兒過敏免疫科高雄

Low FCMR mRNA expression in leukocytes of patients with Kawasaki disease six months after disease onset.

Chang LS, Guo MM, Yan JH, Huang YH, Lo MH, Kuo HC.

Pediatr Allergy Immunol. 2020 Feb 19.

The role of corticosteroids in the treatment of Kawasaki disease.

Chang LS, Kuo HC.

Expert Rev Anti Infect Ther. 2020 Feb;18(2):155-164.

dentification of increased expression of activating Fc receptors and novel findings regarding distinct IgE and IgM receptors in Kawasaki disease.

Chang LS, Ming-Huey Guo M, Lo MH, Kuo HC.

Pediatr Res. 2019 Dec 9. doi: 10.1038/s41390-019-0707-y. Online ahead of print.

PMID: 31816620

Successful treatment in a child with enthesitis-related arthritis involving the sternoclavicular joint: a case report.

Huang PY, Chang LS, Guo MM, Kuo HC.

BMC Pediatr. 2019 Oct 23;19(1):373.

Association between maternal age and outcomes in Kawasaki disease patients.

Huang WD, Lin YT, Tsai ZY, Chang LS, Liu SF, Lin YJ, Kuo HC.

Pediatr Rheumatol Online J. 2019 Jul 19;17(1):46.

Decreased DNA methyltransferases expression is associated with coronary artery lesion formation in Kawasaki disease.

Huang YH, Chen KD, Lo MH, Cai XY, Chang LS, Kuo YH, Huang WD, Kuo HC.

Int J Med Sci. 2019 Apr 25;16(4):576-582.

Decreased incidence of glaucoma in children with asthma using inhaled corticosteroid: a cohort study.

Chang LS, Lee HC, Tsai YC, Shen LS, Li CL, Liu SF, Kuo HC.

Oncotarget. 2017 Nov 1;8(62):105463-105471. doi: 10.18632/oncotarget.22252. eCollection 2017 Dec 1.

CYP2E1 Gene Polymorphisms Related to the Formation of Coronary Artery Lesions in Kawasaki Disease.

Chang LS, Hsu YW, Lu CC, Lo MH, Hsieh KS, Li SC, Chang WC, Kuo HC.

Pediatr Infect Dis J. 2017 Nov;36(11):1039-1043.

l-Arginine-Dependent Epigenetic Regulation of Interleukin-10, but Not Transforming Growth Factor-β, Production by Neonatal Regulatory T Lymphocytes.

Yu HR, Tsai CC, Chang LS, Huang HC, Cheng HH, Wang JY, Sheen JM, Kuo HC, Hsieh KS, Huang YH, Yang KD, Hsu TY.

Front Immunol. 2017 Apr 25;8:487.

The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease.

Chang LS, Lo MH, Li SC, Yang MY, Hsieh KS, Kuo HC.

Oncotarget. 2017 Jan 10;8(2):2044-2052.

Correlation of pandemic (H1N1) 2009 viral load with disease severity and prolonged viral shedding in children.

Li CC, Wang L, Eng HL, You HL, Chang LS, Tang KS, Lin YJ, Kuo HC, Lee IK, Liu JW, Huang EY, Yang KD.

Emerg Infect Dis. 2010 Aug;16(8):1265-72

Acute lymphoblastic leukemia presented as severe jaundice and hyperferritinemia: a case report.

Chang LS, Yu HR, Chen YC, Yeah ST, Tiao MM, Hsiao CC, Sheen JM.

J Pediatr Hematol Oncol. 2011 Apr;33(3):e117-9

Risk factors for mortality of pediatric patients without underlying diseases.

Chang LS, Kuo HC, Wu CC, Yu HR, Wang L, Chang HW, Yang KD.

Pediatr Neonatol. 2011 Feb;52(1):34-7. doi: 10.1016/j.pedneo.2010.12.007.

Etanercept treatment for children with refractory juvenile idiopathic arthritis.

Kuo HC, Yu HR, Wu CC, Chang LS, Yang KD.

J Microbiol Immunol Infect. 2011 Jan 13;44(1):52-56

Higher levels of soluble Fas ligand and transforming growth factor-β after omalizumab treatment: a case report.

Kao SL, Yu HR, Kuo HC, Tsui KY, Wu CC, Chang LS, Liang CD, Chung YH, Yang KD.

J Microbiol Immunol Infect. 2012 Feb;45(1):69-71. doi: 10.1016/j.jmii.2011.12.026. Epub 2012 Jan 13.

A surveillance system to reduce transmission of pandemic H1N1 (2009) influenza in a 2600-bed medical center.

Chu TP, Li CC, Wang L, Hsu LW, Eng HL, You HL, Liu JW, Wei CC, Chang LS, Lee IK, Yang KD.

PLoS One. 2012;7(3):e32731. doi: 10.1371/journal.pone.0032731. Epub 2012 Mar 13.